Investors on Swiss Company Roche Remain Cautious Despite Overall Business Improvement

Swiss pharmaceutical giant Roche has experienced an improved revenue this year. However, it also saw a decline in market cap as its invetors remain cautious on broader industry factors.

Read Full Article

Fund managers boost bets on health care even amid high prices

Last July, when Federal Reserve Chair Janet Yellen spurred a sell-off in healthcare stocks by saying that valuations in shares of biotech companies looked "stretched," portfolio manager Graham Tanaka saw an opportunity.

Read Full Article

Roche seals licensing deal for antibiotic-boosting drug to battle superbugs

Roche has boosted its efforts to tackle antibiotic resistance, striking a deal worth up to $750 million with Japan's Meiji Seika Pharma and Canada's Fedora for a drug that can restore the power of antibiotics to combat infections.

Read Full Article

Roche says will buy U.S. maker of prenatal Down syndrome test

Roche said on Tuesday it will acquire San Jose, CA-based Ariosa Diagnostics, Inc., a molecular diagnostics firm which makes a prenatal test to assess the risk of Down syndrome and other genetic abnormalities.

Read Full Article

AstraZeneca strengthens cancer business with new deals

AstraZeneca moved to strengthen its core oncology business on Tuesday with three deals designed to expand the British drugmaker's reach in treating tumors.

Read Full Article

WPP Digital picks up majority stake in UK digital consultancy Cognifide

Dublin, Ireland-based global communications services firm WPP Digital picked up a majority stake in London, UK-based digital consultancy firm Cognifide for an undisclosed sum in a deal that will deliver mutual benefits to both companies.

Read Full Article

Boston software maker Mendix nabs $25M in funding

Boston, US-based enterprise software maker Mendix nabbed $25 million in venture capital funding led by Battery Ventures to fuel its mission to build a big business in the software industry.

Read Full Article

Roche CEO squelches possible merger with Novartis

Roche Chief Executive Officer Severin Schwan said the founding families of Roche Holding would prefer to remain independent.

Read Full Article

Investors raise concern about Alexion valuation

Alexion Pharmaceuticals Inc sought potential buyers however investors raised concerns about the valuation of the company.

Read Full Article

Roche Buys CMI For $220 Million Plus Contigent Payments

Roche buys CMI, pushing Roche even further as the industry leader for laboratory hematology testing.

Read Full Article

Subscribe to VCpost newsletter

Sign up for our Deals of the Day newsletter.
We will not spam you!

Real Time Analytics